# Alpha Teknova Inc. (TKNO) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $7.34, market value $453 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Alpha Teknova Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 10.4×**. Each dollar of revenue is priced at 10.4×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 6.3×**. The shares trade at 6.3× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -1.6%** (5-yr avg -14.9%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 34.6%**. Alpha Teknova Inc. keeps 34.6% of revenue after the direct cost of what it sells.
- **Operating margin: -36.2%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -42.6%**. The company reported a net loss over the last twelve months.
- **Return on equity: -25.1%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -16.4%**. Return on all capital, debt included, is -16.4%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -16.2%**. Each dollar of assets produces -16.2% of profit.

## Growth
- **Revenue growth (1 yr): 7.4%** (3-yr -0.7%/yr, 5-yr 5.3%/yr). Revenue grew 7.4% over the last year, against 5.3% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 43.9%**. Earnings per share rose 43.9%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.19**. Debt is 0.19 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Alpha Teknova Inc. holds more cash than debt.
- **Current ratio: 4.58** (quick 4.58). Current assets cover the next year's liabilities 4.58 times.
- **Altman Z-score: 8.90**. A Z-score of 8.90 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Alpha Teknova Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (6 analysts). 6 analysts cover Alpha Teknova Inc.; the consensus is strong_buy, with an average price target of $9.67 (+32% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 33.5%** (YTD 84.5%, 3-mo 32.3%). The shares are up 33.5% over twelve months including dividends.
- **From 52-week high: -22.6%** (284.3% above the low). Trading 23% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 45**. An RSI of 45 is neutral.
- **Beta (1 yr): 1.40** (volatility 81%). Beta of 1.40 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=TKNO · Page: https://foliofundamentals.com/stocks/tkno

Not investment advice.